Detalles de la búsqueda
1.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Biol Blood Marrow Transplant
; 26(12): 2299-2305, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822845
2.
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1810-1817, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128326
3.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128325
4.
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Transfusion
; 59(11): 3442-3447, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625183
5.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29448057
6.
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Biol Blood Marrow Transplant
; 24(3): 627-632, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29197681
7.
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(3): 549-554, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247781
8.
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Biol Blood Marrow Transplant
; 22(1): 119-24, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341397
9.
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
Cancer
; 121(11): 1809-16, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25649994
10.
Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.
Biol Blood Marrow Transplant
; 20(5): 724-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24530426
11.
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Biol Blood Marrow Transplant
; 20(10): 1560-5, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933658
12.
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(3): 370-4, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24315846
13.
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells.
Br J Haematol
; 185(3): 570-573, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30125934
14.
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Am J Hematol
; 89(1): 83-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24108528
15.
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Bone Marrow Transplant
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486114
16.
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone Marrow Transplant
; 59(1): 101-106, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923831
17.
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Cancer Chemother Pharmacol
; 2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957436
18.
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant
; 58(9): 1033-1041, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37386253
19.
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Bone Marrow Transplant
; 58(4): 386-392, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585459
20.
Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients.
Br J Haematol
; 176(1): 132-135, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27073182